Treatment of respiratory tract diseases and infections with glutathione compositions
AssigneeRenovion, Inc.
InventorsDan COPELAND, Carolyn DURHAM, Thomas E. RICHARDSON
Life of this patent
Estimating the term…
Abstract
The application is directed to a method of inhibiting or reducing growth of clinical isolate bacteria comprising contacting the clinical isolate with a composition comprising glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof.
Claims21
1-99. (canceled)
A method of inhibiting or reducing growth of a clinical isolate bacteria comprising contacting the clinical isolate bacteria with a composition comprising (a) glutathione or a pharmaceutically-acceptable salt thereof, and (b) ascorbic acid or a pharmaceutically acceptable salt thereof, wherein the composition (i) inhibits or reduces growth of the clinical isolate bacteria and/or (ii) inhibits or reduces formation of a bacteria biofilm comprising the clinical isolate bacteria;
- wherein the clinical isolate bacteria is selected from Burkholderia cepacia, methicillin resistant Staphylococcus aureus (MRSA), Staphylococcus aureus, Moraxella catarrhalis, Stenotrophomonas maltophilia, Acinetobacter baumannii, or any combination thereof.
Dependencies are inferred from the claim text.